IP Verse

Natural Combination Hormone Replacement Formulations And Therapies - EP2782584

The patent EP2782584 was granted to Therapeuticsmd on Jun 9, 2021. The application was originally filed on Nov 21, 2012 under application number EP12850845A. The patent is currently recorded with a legal status of "Revoked".

EP2782584

THERAPEUTICSMD
Application Number
EP12850845A
Filing Date
Nov 21, 2012
Status
Revoked
Nov 10, 2023
Grant Date
Jun 9, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DR SCHONMar 9, 2022DR SCHONADMISSIBLE
GENERICS UKMar 9, 2022ELKINGTON AND FIFEADMISSIBLE
RIECKMar 9, 2022FUCHS PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2003077297
INTERNATIONAL-SEARCH-REPORTUS2003124182
INTERNATIONAL-SEARCH-REPORTUS2008299220
INTERNATIONAL-SEARCH-REPORTUS2010137271
INTERNATIONAL-SEARCH-REPORTUS2010316724
INTERNATIONAL-SEARCH-REPORTUS2011182997
INTERNATIONAL-SEARCH-REPORTUS2011262494
INTERNATIONAL-SEARCH-REPORTUS4900734
INTERNATIONAL-SEARCH-REPORTUS6077531
OPPOSITIONUS13684002
OPPOSITIONUS2003077297
OPPOSITIONUS2010137271
OPPOSITIONUS2011312928
OPPOSITIONUS4196188
OPPOSITIONUS4900734
OPPOSITIONUS4963540
OPPOSITIONWO9740823
SEARCHUS2003077297
SEARCHUS2011312928
SEARCHUS4900734

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Abitec, "Safety data sheet: Capmul® MCM NF", ABITEC, (20110724), pages 1 - 5, XP055906278-
OPPOSITION- Anonymous, "Progesterone injection USP in sesame oil for intramuscular use only Rx only", Watson Laboratories, Inc, (20070101), pages 1 - 7, XP055905396-
OPPOSITION- Anonymous, "Prometrium (progesterone, USP) Capsules 100 mg Capsules 200 mg", Solvay Pharmaceuticals, Inc, (20090601), pages 1 - 33, XP055907204-
OPPOSITION- B. John Cannon, Et Al., "Emulsions, Microemulsions and Lipid-based Drug Delivery Systems for Drug Solubilization and Delivery - Part II: Oral Applications", Water Insoluble Drug Formulation Second Edition, (20080101), pages 227 - 254, XP055466108-
OPPOSITION- Gattefossé, "Gelucire® 44/14 - Self-emulsifying excipient for solubility and oral bioavailability enhancement", (20190101), pages 1 - 24, XP055905389-
OPPOSITION- MCAULEY et al., "Oral Administration of Mi- June 1996 cronized Progesterone: A Review and More Experience", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol. 16, XP000886527-
OPPOSITION- The North American Menopause Society, "The 2012 Hormone Therapy Position Statement of The North American Meno- pause Society", Menopause, (20120301), vol. 19, no. 3, pages 257 - 271, XP055907213-
OPPOSITION- H. N. PRAJAPATI et al., "A Comparative Evaluation of Mono-, Di- and Triglyceride of Me- dium Chain Fatty Acids by Lipid/Surfactant/Water Phase Diagram, Solubility Determi- nation and Dispersion Testing for Application in Pharmaceutical Dosage Form Devel- opment", Pharm. Res., (20110823), vol. 29, pages 285 - 305, XP019993288
OPPOSITION- Sitruk-Ware, R. et al, "Oral micronized progesterone - Bioavailability pharmacokinetics, pharmacological and therapeutic implications - A review", CONTRACEPTION, US , (19871001), vol. 36, no. 4, doi:10.1016/0010-7824(87)90088-6, ISSN 0010-7824, pages 373 - 402, XP023167138
OPPOSITION- POUTON, C.W. et al., "Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies", A dvanced Drug Delivery Reviews, (20080000), vol. 60, doi:10.1016/j.addr.2007.10.010, pages 625 - 637, XP022476854

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents